Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial.

导出 LinkOut

翻译打印收藏纠错

作者： Guoqi,Cai ^[1] ; Laura L,Laslett ^[2] ; Michael A,Bowes ^[3] ; Philip G,Conaghan ^[4] ; Flavia,Cicuttini ^[5] ; Anita E,Wluka ^[5] ; Lyn,March ^[6] ; Catherine,Hill ^[7] ; Tania,Winzenberg ^[2] ; Graeme,Jones ^[2] ; Dawn,Aitken ^[2]

作者单位： Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, China; Menzies Institute for Medical Research, University of Tasmania, TAS, Hobart, Australia. Electronic address: Guoqi.Cai@utas.edu.au. ^[1] Menzies Institute for Medical Research, University of Tasmania, TAS, Hobart, Australia. ^[2] Imorphics Ltd, Manchester, UK. ^[3] Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK. ^[4] Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. ^[5] Institute of Bone and Joint Research, The University of Sydney, Royal North Shore Hospital, Sydney, Australia. ^[6] Department of Rheumatology, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia. ^[7]

关键词 Bone area Bone shape Methylprednisolone Osteoarthritis Zoledronic acid